News
Rozlyn Khan celebrates the removal of her chemo port, marking a significant milestone in her battle against Stage 4 breast ...
Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...
Boost your health with expert advice! A Harvard doctor reveals key food items that may help prevent cancer risk. Check out ...
17h
Zacks.com on MSNBMY Focuses on Label Expansion of Drugs: Will This Revive Growth?BMY's banks on label expansion of drugs like Sotyktu and Opdivo to boost sales in the wake of generic competition for legacy ...
The safety and efficacy profiles of these classes of therapeutics are continuously being enhanced by the development of novel drug formulations, or innovative drug delivery technologies, etc. In ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.
Relacorilant plus nab-paclitaxel improved PFS and showed a trend toward longer OS in platinum-resistant ovarian cancer in ROSELLA.
Chemotherapy is a vital treatment for people with all forms of cancer. It's a process that uses drugs designed to kill, ...
A University of Chicago spinout has raised $4 million in seed funding to develop a unique, saliva-based test for oral cancers ...
DelveInsight's, “Bladder Cancer Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ ...
14h
News-Medical.Net on MSNNew drug combination shows high remission rates in acute myeloid leukemiaA combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid ...
AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results